FDA Announces Comprehensive Regenerative Medicine Policy Framework

Framework aims to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy SILVER SPRING, Md., Nov. 16, 2017 -- (Healthcare Sales & Marketing Network) -- Today the U.S. Food and Drug Administration an... Regenerative Medicine, FDA U.S. Food and Drug Administration

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2043188

Source: HSMN NewsFeed - November 16, 2017 Category: Pharmaceuticals Source Type: news

More News: Food and Drug Administration (FDA) | Marketing